Ascend Capital adds AMETEK (AME) to its portfolio

AMETEK (AME) : Ascend Capital added new position in AMETEK during the most recent quarter end. The investment management firm now holds 450,000 shares of AMETEK which is valued at $20.8 Million , the company said in a statement filed on May 13, 2016 with the SEC.AMETEK makes up approximately 2.12% of Ascend Capital’s portfolio.

Other Hedge Funds, Including , Ikos Cif Ltd reduced its stake in AME by selling 4,405 shares or 93.62% in the most recent quarter. The Hedge Fund company now holds 300 shares of AME which is valued at $13,896. AMETEK makes up approx 0.03% of Ikos Cif Ltd’s portfolio.Blackrock Institutional Trust Company N.a. reduced its stake in AME by selling 4,741 shares or 0.08% in the most recent quarter. The Hedge Fund company now holds 6,054,956 shares of AME which is valued at $280.5 Million. AMETEK makes up approx 0.05% of Blackrock Institutional Trust Company N.a.’s portfolio.Tiaa Cref Investment Management reduced its stake in AME by selling 40,870 shares or 3.71% in the most recent quarter. The Hedge Fund company now holds 1,061,976 shares of AME which is valued at $49.6 Million. AMETEK makes up approx 0.04% of Tiaa Cref Investment Management’s portfolio.Pacad Investment Ltd. reduced its stake in AME by selling 8,400 shares or 50.91% in the most recent quarter. The Hedge Fund company now holds 8,100 shares of AME which is valued at $378,594. AMETEK makes up approx 0.04% of Pacad Investment Ltd.’s portfolio.

AMETEK opened for trading at $47.99 and hit $48.14 on the upside on Wednesday, eventually ending the session at $47.93, with a gain of 0.42% or 0.2 points. The heightened volatility saw the trading volume jump to 11,11,657 shares. Company has a market cap of $11,187 M.

On the company’s financial health, AMETEK reported $0.57 EPS for the quarter, based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus estimate of $0.57. The company had revenue of $944.40 million for the quarter, compared to analysts expectations of $965.26 million. The company’s revenue was down -4.0 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.63 EPS.

Investors should note that on May 5, 2016, AMETEK announced a cash dividend of $0.0900. The company’s management has announced Jun 14, 2016 as the ex-dividend date and fixed the record date on Jun 16, 2016. The payable date has been fixed on Jun 30, 2016.

Many Wall Street Analysts have commented on AMETEK. Company shares were Downgraded by Robert W. Baird on Apr 29, 2016 to ” Neutral”, Firm has raised the Price Target to $ 51 from a previous price target of $49 .

AMETEK Inc. (AMETEK) is a manufacturer of electronic instruments and electromechanical devices with operations in North America Europe Asia and South America. AMETEK markets and sells its products through two groups: Electronic Instruments (EIG) and Electromechanical (EMG). The Company’s EIG segment designs and manufactures advanced instruments for the process aerospace power and industrial markets. It offers process control instruments for the oil and gas petrochemical pharmaceutical semiconductor and factory automation industries. The Company’s EMG segment offers electrical connectors and electronics packaging used in aerospace and defense medical and industrial applications as well as its advanced technical motor and motion control products which are used in a range of medical devices office and business equipment factory automation robotics and other applications.

Leave a Reply

AMETEK - Is it time to Sell?

Top Brokerage Firms are advising their investors on AMETEK. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.